The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety

Pharmacology Biochemistry and Behavior

Volumn 66, Issue 1, 2000, Pages 65-72

  File, Sandra E ^a   Kenny, Paul J ^a   Cheeta, Survjit ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

5 HT(1A) receptor; 8 OH DPAT; Anxiety; Dorsal hippocampus; Glycine; M1 muscarinic receptor; McN A 343; Mecamylamine; Nicotine; Pirenzepine; Rat

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; MECAMYLAMINE; MUSCARINIC M1 RECEPTOR AGONIST; MUSCARINIC M1 RECEPTOR ANTAGONIST; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT; PIRENZEPINE; POSTSYNAPTIC RECEPTOR; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; AVOIDANCE BEHAVIOR; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ESCAPE BEHAVIOR; HIPPOCAMPUS; HYPOTHALAMUS; MAZE TEST; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SEROTONINERGIC SYSTEM; SOCIAL INTERACTION; SOCIAL PHOBIA;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0034109617     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00198-2     Document Type: Article

References (71)

1. Andrade R. Whole-cell and perforated-patch recording of serotonin responses in the rat hippocampus. J. Chem. Neuroanat. 5:1992;339-341.
2. 1A receptors in the median raphé nucleus and the dorsal hippocampus mediate anxiolytic and anxiogenic effects respectively. Eur. J. Pharmacol. 264:1994;259-264.
3. Balfour D.J.K., Benwell M.E.M., Graham C.A., Vale A.L. Behavioural and adrenocortical responses to nicotine measured in rats with selective lesions of the 5-hydroxytryptaminergic fibres innervating the hippocampus. Br. J. Pharmacol. 89:1986;341-347.
4. 1A receptor agonist 8-OH-DPAT. Brain Res. 640:1994;223-228.
5. Brioni J.D., O'Neill A.B., Kim D.J., Buckley M.J., Decker M.W., Arneric S.P. Anxiolytic-like effects of the novel cholinergic channel activator ABT-418. J. Pharmacol. Exp. Ther. 271:1994;353-361.
6. 1A-receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat. Eur. J. Pharmacol. 234:1993;215-221.
7. 1A receptor agonist. Psychopharmacology (Berlin). 94:1988;84-91.
8. Eison A.S., Eison M.S., Stanley M., Riblet L.A. Serotonergic mechanisms in the behavioral effects of buspirone and gepirone. Pharmacol. Biochem. Behav. 24:1986;701-707.
9. Engel J.A., Hjorth S., Svensson K., Carlsson A., Liljequist S. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(Di-n-propylamino)tetralin (8-OH-DPAT). Eur. J. Pharmacol. 105:1984;365-368.
10. Fernandes C., File S.E. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol. Biochem. Behav. 54:1996;31-40.
11. File S.E. One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology (Berlin). 100:1990;281-282.
12. File S.E. Behavioural detection of anxiolytic action. Elliot J.M.et al. Experimental approaches to anxiety and depression. 1992;25-44 John Wiley, London.
13. File S.E. The interplay of learning and anxiety in the elevated plus-maze. Behav. Brain Res. 58:1993;199-202.
14. 1A-receptor ligands in dorsal raphé and ventral hippocampus. Pharmacol. Biochem. Behav. 54:1996;123-128.
15. File S.E., Zangrossi H. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology (Berlin). 110:1993;240-244.
16. File S.E., Andrews N., Zharkovsky A. Handling habituation and chlordiazepoxide have different effects on GABA and 5-HT function in the frontal cortex and hippocampus. Eur. J. Pharmacol. 190:1990;239-244.
17. 1A receptor modulation of anxiety in two ethological animal tests. J. Neurosci. 16:1996;4810-4815.
18. File S.E., Gonzalez L.E., Andrews N. Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic1 receptors. Behav. Neurosci. 112:1998;352-359.
19. File S.E., Gonzalez L.E., Gallant R. Role of the basolateral nucleus of the amygdala in the formation of a phobia. Neuropsychopharmacology. 19:1998;397-405.
20. File S.E., Gonzalez L.E., Gallant R. Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety. Neuropsychopharmacology. 21:1999;312-320.
21. File S.E., Johnston A.L., Baldwin H.A. Anxiolytic and anxiogenic drugs. Changes in behaviour and endocrine responses Stress Med. 4:1988;221-230.
22. File S.E., Kenny P.J., Ouagazzal A.M. Bimodal modulation by nicotine of anxiety in the social interaction test. Role of the dorsal hippocampus Behav. Neurosci. 112:1998;1423-1429.
23. File S.E., Zangrossi H. Jr., Andrews N. Social interaction and elevated plus-maze tests. Changes in release and uptake of 5-HT and GABA Neuropharmacology. 3:1993;217-221.
24. File S.E., Curle P.F., Baldwin H.A., Neal N.J. Anxiety in the rat is associated with a decreased release of 5-HT and glycine from the hippocampus. Neurosci. Lett. 83:1987;318-322.
25. File S.E., Zangrossi H. Jr., Sanders F.L., Mabbutt P.S. Raised corticosterone in the rat after exposure to the elevated plus-maze. Psychopharmacology (Berlin). 113:1994;543-546.
26. File S.E., Zangrossi H. Jr., Viana M., Graeff F.G. Trial 2 in the elevated plus-maze. A different form of fear? Psychopharmacology (Berlin). 111:1993;491-494.
27. Freund T.F., Buzsáki G. Interneurons of the hippocampus. Hippocampus. 6:1996;347-470.
28. Goisman R.M., Allsworth J., Rodgers M.P., Warshaw M.G., Goldenberg I., Vasile R.G., Rodriguez-Villa F., Mallya G., Keller M.B. Simple phobia as a comorbid anxiety disorder. Dep. Anx. 7:1998;105-112.
29. Gonzalez L.E., File S.E. A 5-min experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphé nucleus. J. Neurosci. 17:1997;1505-1511.
30. Gonzalez L.E., Ouagazzal A.M., File S.E. Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphé reveals differential GABAergic control in two animal tests of anxiety. Eur. J. Neurosci. 10:1998;3673-3680.
31. Graeff F.G., Silveira M.C.L., Nogueira R.L., Audi E.A., Oliveira R.M.W. Role of the amygdala and periaqueductal gray in anxiety and panic. Behav. Brain Res. 58:1993;123-131.
32. Graeff F.G., Viana M., Tomaz C. The elevated T-maze, a new experimental model of anxiety and memory. Effect of diazepam Braz. J. Med. Biol. Res. 26:1993;1-4.
33. Gray J.A. Precis of the neuropsychology of anxiety. an inquiry into the functions of the septo-hippocampal system Behav. Brain Sci. 5:1982;469-534.
34. 1-like and GABA receptors in the dorsal raphé nucleus of the rat. Neuropharmacology. 27:1988;993-1001.
35. Hogg S., Andrews N., File S.E. Contrasting behavioural effects of 8-OH DPAT in the dorsal raphé nucleus and ventral hippocampus. Neuropharmacology. 33:1994;343-348.
36. Holmes A., Rodgers R.J. Responses of swiss-webster mice to repeated plus-maze experience. Further evidence for a qualitiative shift in emotional state? Pharmacol. Biochem. Behav. 60:1998;473-488.
37. Irvine E.E., Cheeta S., File S.E. Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav. Pharmacol. 10:1999;691-697.
38. 1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J. Pharmacol. Exp. Ther. 272:1995;920-929.
39. 1A agonistic anxiolytic. Neuropharmacology. 30:1991;475-480.
40. 1 receptors. Neuropharmacology. 39:2000;300-307.
41. Kenny, P. J.; File, S. E.; Neal, M. J.: Evidence for a dual influence of nicotinic acetylcholine receptors on hippocampal serotonin release. Br. J. Pharmacol. (in press).
42. Kostowski W, Plaźnik A., Stefański R. Intra-hippocampal buspirone in animal models of anxiety. Eur. J. Pharmacol. 168:1989;393-396.
43. 3H]5-HT from rat hippocampal slices. Neuropharmacology. 35:1996;1769-1777.
44. Lipska B.K., Jaskiw G.E., Weinberger D.R. Dorsal hippocampal lesion abolishes the response to FG-7142 in the rat. Pharmacol. Biochem. Behav. 40:1991;169-172.
45. 7) implicated in the regulation of mammalian circadian rhythms. Neuron. 11:1993;449-458.
46. Marks I.M. Fears, phobias and rituals. 1987;Oxford University Press, New York.
47. Matsuo M., Kataoka Y., Mataki S., Kato Y., Oi K. Conflict situation increases serotonin release in rat dorsal hippocampus. In vivo study with microdialysis and vogel test Neurosci. Lett. 215:1996;197-200.
48. Menard J., Treit D. The septum and the hippocampus differentially mediate anxiolytic effects of R(+)-8-OH-DPAT. Behav. Pharmacol. 9:1998;93-101.
49. 1A receptors on elevated plus maze exploration after a single restraint experience. Behav. Brain Res. 77:1996;215-218.
50. Ouagazzal A.M., Kenny P.J., File S.E. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine. Psychopharmacology (Berlin). 144:1999;54-60.
51. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
52. 1A) receptors in the anticonflict activity of β-adrenoceptor antagonists. Neuropharmacology. 34:1995;1211-1217.
53. 1A receptors in the anticonflict effect of ipsapirone. Neuropharmacology. 33:1994;1109-1115.
54. Rodgers R.J., Johnson N.J.T. Cholecystokinin and anxiety. Promises and pitfalls Crit. Rev. Neurobiol. 9:1995;345-369.
55. Rodgers R.J., Lee C., Shepherd J.K. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology (Berlin). 106:1992;102-110.
56. Rodgers R.J., Shepherd J.K. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology (Berlin). 113:1993;237-242.
57. 1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat. Eur. J. Pharmacol. 249:1993;341-351.
58. Smythe J.W., Bhatnagar S., Murphy D., Timothy C., Costall B. The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the black-white box test. Brain Res. Bull. 45:1998;89-93.
59. 1A receptor agonists. Neuropharmacology. 32:1993;977-985.
60. Tao R., Auerbach S.B. Differential effect of NMDA on extracellular serotonin in midbrain raphe and forebrain sites. J. Neurochem. 66:1996;1067-1075.
61. Taukulis H.K., McKay R.W. Postdrug retention of diazepam's effects on habituation to a novel environment in an animal model of anxiety. Behav. Neural Biol. 53:1992;286-293.
62. Treit D., Menard J. Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions. Behav. Neurosci. 111:1997;653-658.
63. Treit D., Menard J., Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav. 44:1993;463-469.
64. Tyrer P. Choice of treatment in anxiety. Tyrer P. Psychopharmacology of anxiety. 1989;254-282 Oxford Medical Publications, Oxford, UK.
65. Vizi E.S., Kiss J.P. Neurochemistry and pharmacology of the major hippocampal transmitter systems. Synaptic and nonsynaptic interactions Hippocampus. 8:1998;566-607.
66. Voigt J.-P., Rex A., Sohr R., Fink H. Hippocampal 5-HT and NE release in transgenic rat TGR(mREN2)27 related to behavior on the elevated plus maze. Eur. Neuropsychopharmacol. 9:1999;279-285.
67. Whitton P., Curzon G. Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus. Psychopharmacology (Berlin). 100:1990;138-140.
68. Whitton P.S., Richards D.A., Biggs C.S., Fowler L.J. N-methyl-D-aspartate receptors modulate extracellular 5-hydroxytryptamine concentration in rat hippocampus and striatum in vivo. Neurosci. Lett. 169:1994;215-218.
69. 1A receptor agonist 8-OH-DPAT in the rat. Eur. J. Pharmacol. 219:1992;105-112.
70. Wright I.K., Upton N., Marsden C.A. Effect of established and putative anxiolytics on extracellular 5-HT and 5-HIAA in the ventral hippocampus of rats during behaviour on the elevated X-maze. Psychopharmacology (Berlin). 109:1992;338-346.
71. Zangrossi H., File S.E. Behavioural consequences in animal tests of anxiety and exploration of exposure to cat odour. Brain Res. Bull. 29:1992;381-388.